Journal Article
Research Support, Non-U.S. Gov't
Add like
Add dislike
Add to saved papers

Synthesis of magnetically separable Bi2O4/Fe3O4 hybrid nanocomposites with enhanced photocatalytic removal of ibuprofen under visible light irradiation.

Water Research 2016 September 2
Ibuprofen (IBU) is one of the representative persistent organic pollutants (POPs) which can cause severe adverse effects in humans and wildlife. Therefore, effectively removing IBU from water is a worldwide necessity. In this study, a novel superparamagnetic Bi2O4/Fe3O4 nanocomposite was successfully prepared by an in-situ growth method and utilized for photocatalytic removal of IBU. The structural characterization of the Bi2O4/Fe3O4 nanocomposite indicates that the monodisperse Fe3O4 nanoparticles of diameter 10 nm are highly assembled on the Bi2O4 nanorods of diameter 120 nm. Under visible light irradiation, using an optimum molar ratio of Bi2O4/Fe3O4 (1:2.5) resulted in a complete photocatalytic degradation of IBU within 2 h, which is a 1.7 times higher efficiency than pure Bi2O4, and a complete mineralization of IBU with a prolonged irradiation time of 4 h. In addition, the potential practicality of Bi2O4/Fe3O4 (1:2.5) was also demonstrated by the efficient photocatalytic degradation of IBU in actual drinking water. The photocatalytic mechanisms of Bi2O4/Fe3O4 (1:2.5) were revealed, indicating that the enhanced photocatalytic performance was mainly attributed to the accelerated separation of electron-hole pairs after surface modification of Fe3O4, and that the photogenerated h(+) was the primary reactive species for the photocatalytic removal of IBU. Furthermore, the Bi2O4/Fe3O4 (1:2.5) can be magnetically recycled and shows good reusability without significant loss of photocatalytic activity or structural change even after reuse over five cycles, showing a promising application for the photocatalytic degradation of POPs from water.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app